PIPERNO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 23.544
AS - Asia 10.329
EU - Europa 8.927
SA - Sud America 1.483
Continente sconosciuto - Info sul continente non disponibili 785
AF - Africa 231
OC - Oceania 18
Totale 45.317
Nazione #
US - Stati Uniti d'America 22.081
SG - Singapore 3.726
CN - Cina 2.364
IT - Italia 1.705
HK - Hong Kong 1.526
CA - Canada 1.318
RU - Federazione Russa 1.316
DE - Germania 1.094
SE - Svezia 1.090
VN - Vietnam 1.084
BR - Brasile 1.077
IE - Irlanda 968
UA - Ucraina 860
GB - Regno Unito 495
FR - Francia 425
BD - Bangladesh 313
IN - India 312
FI - Finlandia 276
AT - Austria 156
AR - Argentina 142
KR - Corea 140
TR - Turchia 127
IQ - Iraq 104
NL - Olanda 96
JP - Giappone 94
PK - Pakistan 89
ID - Indonesia 84
ES - Italia 79
MX - Messico 68
ZA - Sudafrica 66
BE - Belgio 65
PL - Polonia 63
DK - Danimarca 61
SA - Arabia Saudita 61
EC - Ecuador 54
CO - Colombia 51
PH - Filippine 48
UZ - Uzbekistan 48
VE - Venezuela 47
PE - Perù 38
BG - Bulgaria 31
MA - Marocco 28
ET - Etiopia 27
CL - Cile 26
KE - Kenya 25
LT - Lituania 25
MY - Malesia 25
PY - Paraguay 22
EG - Egitto 20
CH - Svizzera 19
NP - Nepal 19
TN - Tunisia 19
JO - Giordania 17
RO - Romania 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
CR - Costa Rica 15
IR - Iran 15
DO - Repubblica Dominicana 14
BO - Bolivia 13
OM - Oman 13
CZ - Repubblica Ceca 12
HU - Ungheria 12
KZ - Kazakistan 12
DZ - Algeria 11
JM - Giamaica 11
TW - Taiwan 10
IL - Israele 9
TH - Thailandia 9
UY - Uruguay 9
AZ - Azerbaigian 8
GR - Grecia 8
PS - Palestinian Territory 8
BH - Bahrain 7
HR - Croazia 7
KG - Kirghizistan 7
PA - Panama 7
RS - Serbia 7
SN - Senegal 7
AM - Armenia 6
EU - Europa 6
PT - Portogallo 6
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
NG - Nigeria 5
NI - Nicaragua 5
NO - Norvegia 5
SV - El Salvador 5
GE - Georgia 4
LB - Libano 4
MD - Moldavia 4
SC - Seychelles 4
AL - Albania 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MT - Malta 3
NZ - Nuova Zelanda 3
QA - Qatar 3
Totale 44.479
Città #
Ann Arbor 3.013
Singapore 2.163
Ashburn 2.002
Woodbridge 1.748
Hong Kong 1.491
Fairfield 1.438
Houston 1.355
San Jose 1.038
Chandler 1.026
Toronto 1.004
Dublin 934
Jacksonville 910
Wilmington 753
Frankfurt am Main 674
Seattle 596
Milan 566
Dearborn 565
Cambridge 514
New York 496
Santa Clara 391
Princeton 367
Los Angeles 361
Beijing 343
Chicago 311
Ho Chi Minh City 296
The Dalles 294
Dallas 279
Hanoi 257
Nanjing 236
Shanghai 189
Hefei 185
Lauterbourg 175
Lawrence 174
Lachine 155
Rome 151
Altamura 135
Seoul 129
Vienna 129
Council Bluffs 125
Buffalo 123
Moscow 113
São Paulo 111
Boardman 106
San Diego 97
Orem 77
Nanchang 75
Munich 73
Helsinki 72
Andover 67
Guangzhou 66
Shenyang 65
Tokyo 60
London 57
Brooklyn 54
Brussels 54
Hebei 54
Montreal 53
Denver 49
Jinan 49
Changsha 48
Phoenix 48
Dong Ket 47
Jakarta 45
Ottawa 44
Turin 44
Da Nang 43
Tianjin 43
Rio de Janeiro 42
Tashkent 41
Jiaxing 40
Turku 40
Warsaw 40
Atlanta 37
Belo Horizonte 37
San Francisco 37
Chennai 36
Falls Church 36
Boston 35
Dhaka 35
Nuremberg 34
Salt Lake City 34
Zhengzhou 34
Haiphong 32
Baghdad 31
Columbus 29
Philadelphia 29
Tampa 29
Johannesburg 28
Lahore 27
Addis Ababa 24
Mountain View 24
Norwalk 24
Fremont 23
Ningbo 23
Stockholm 23
Mumbai 22
Paris 22
Quito 22
Washington 22
Amsterdam 21
Totale 29.818
Nome #
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 840
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 699
Hepcidin regulation in a mouse model of acute hypoxia 596
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 450
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 415
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 412
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 387
Hif1a: A putative modifier of hemochromatosis 386
Idiopathic erythrocytosis: a germline disease? 384
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 384
Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation 356
Juvenile Hemochromatosis 353
Inherited iron overload disorders 351
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 351
Type 3 hemochromatosis and beta-thalassemia trait 343
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 340
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 338
Hepcidin regulation in a mouse model of acute hypoxia 338
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 335
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 333
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 332
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 332
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 328
Unexplained isolated hyperferritinemia without iron overload 328
Circulating factors are involved in hypoxia-induced hepcidin suppression 320
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 315
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 310
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 308
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 305
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 303
Early impairment of large artery structure and function in Type I diabetes mellitus 301
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 300
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 299
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 297
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 294
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 294
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 292
Hepatocellular carcinoma in Gaucher disease: an international case series 287
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 286
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 286
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 286
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 285
Ferroportin disease: A novel SLC40A1 mutation 283
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 283
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 282
Hyperferritinemia and diagnosis of type 1 Gaucher disease 282
Increased serum ferritin is common in men with essential hypertension 279
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 277
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 275
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 275
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 272
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 272
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 269
Ceruloplasmin variants might have different effects in different iron overload disorders 269
Different cortical excitability profiles in hereditary brain iron and copper accumulation 266
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 266
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 264
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 263
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 262
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 262
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 262
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 261
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: The causes might be more heterogeneous than in thalassaemia 260
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 259
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 257
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 257
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 253
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 253
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 252
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 252
Effects of hypobaric hypoxia at high altitude on humoral regulation of blood pressure and body fluids. results of highcare project 252
Commentary 252
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 248
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 247
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 247
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 244
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 242
The iron status of Italian subjects with beta-thalassemia trait 240
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 239
Haemochromatosis in patients with β-thalassaemia trait 239
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 239
Biochemical and genetic defects underlying human congenital hypotransferrinemia 239
Homozygous deletion of HFE: The Sardinian hemochromatosis? 238
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 238
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 238
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 235
Natural history of juvenile haemochromatosis 233
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 232
Myelodysplastic Syndromes and Iron Chelation Therapy 230
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 228
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 227
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 225
Erythrocyte ferritin in thalassemia syndromes 224
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 223
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 221
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (c70r) 220
Erythrocyte ferritin in patients on chronic hemodialysis treatment 220
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 218
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 218
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 217
Totale 29.559
Categoria #
all - tutte 144.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.334 0 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20255.730 396 675 231 241 565 176 225 288 740 815 496 882
2025/202614.934 1.331 757 1.018 1.460 1.782 795 2.094 665 1.207 1.265 1.425 1.135
2026/20271.238 1.041 197 0 0 0 0 0 0 0 0 0 0
Totale 45.317